Screening for neuroblastoma and age-specific incidence.
作者信息
Moe P J
机构信息
Department of Paediatrics, University of Trondheim, Norway.
出版信息
Acta Paediatr. 1999 Apr;88(4):362-4. doi: 10.1080/08035259950169693.
PMID:10342530
Abstract
摘要
相似文献
1
Screening for neuroblastoma and age-specific incidence.
Acta Paediatr. 1999 Apr;88(4):362-4. doi: 10.1080/08035259950169693.
2
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
Lancet. 1991 Feb 9;337(8737):344-6. doi: 10.1016/0140-6736(91)90957-q.
3
Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Prog Clin Biol Res. 1994;385:383-8.
4
Screening for neuroblastoma.
Lancet. 1987 Nov 21;2(8569):1204.
5
Screening for neuroblastoma in North America--preliminary results from the Quebec project.
Prog Clin Biol Res. 1991;366:585-94.
6
Results of mass screening for neuroblastoma in Sapporo, Japan.
Prog Clin Biol Res. 1991;366:595-601.
7
Mass screening for neuroblastoma in infants.
Discov Med. 2020 Sep-Oct;30(160):63-70.
8
The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
Oncol Rep. 1998 May-Jun;5(3):631-3. doi: 10.3892/or.5.3.631.
9
Mass screening for neuroblastoma in Japan.
Pediatr Hematol Oncol. 1991 Apr-Jun;8(2):93-109. doi: 10.3109/08880019109033437.
10
Screening for neuroblastoma (NB) in North America: the Quebec Project.
Prog Clin Biol Res. 1994;385:377-82.
Zotero 插件